Adaptive Biotechnologies
ADPT
ADPT
207 hedge funds and large institutions have $859M invested in Adaptive Biotechnologies in 2024 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 67 increasing their positions, 45 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more call options, than puts
Call options by funds: $178K | Put options by funds: $163K
0.05% more ownership
Funds ownership: 97.04% → 97.09% (+0.05%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
207
Holding in Top 10
1
Calls
$178K
Puts
$163K
Top Buyers
| 1 | +$14.3M | |
| 2 | +$11.2M | |
| 3 | +$3.92M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.02M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$2.93M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$13.1M | |
| 3 | -$7.64M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$5.4M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
-$5.4M |